CDT Equity (CDT) Earnings Yield: History & Chart

CDT Equity Inc.(CDT)

Biotechnology · Naples, FL

$0.87-0.05 (-5.43%)

Delayed quote: Oct 6, 2026, 1:04 PM EDT

About CDT Equity Inc.

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company’s pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto’s thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.

Naples, FL

4 employees

www.cdtequity.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jamie Bligh

View full financials

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
CDT Equity Inc. (CDT)	$668915.00	N/A	N/A	N/A	N/A
HCW Biologics Inc. (HCWB)vs ›	$559702.00	N/A	N/A	N/A	N/A
Ridgetech, Inc. (RDGT)vs ›	$791587.00	N/A	233.12%	232.94%	366.47%
Bluejay Diagnostics, Inc. (BJDX)vs ›	$837084.00	N/A	N/A	N/A	N/A
XORTX Therapeutics Inc. (XRTX)vs ›	$487356.00	N/A	79.57%	139.63%	139.63%
Bone Biologics Corporation (BBLG)vs ›	$850879.00	N/A	30990441.81%	30990441.81%	30990441.81%
Decoy Therapeutics Inc. (DCOY)vs ›	$851149.00	N/A	N/A	N/A	N/A
China SXT Pharmaceuticals, Inc. (SXTC)vs ›	$874437.00	N/A	0.00%	0.00%	0.00%
Sunshine Biopharma, Inc. (SBFM)vs ›	$880215.00	N/A	N/A	N/A	N/A
GlucoTrack, Inc. (GCTK)vs ›	$885939.00	N/A	N/A	N/A	N/A

NAME

MARKET CAP

EARNINGS YIELD

TTM

CDT Equity Inc. (CDT)

$668915.00

N/A

HCW Biologics Inc. (HCWB)vs ›

$559702.00

N/A

Ridgetech, Inc. (RDGT)vs ›

$791587.00